Skip to main content

Health & Medicine

PREMIA and Lind Form Lind Asia to Expand AI-Powered Clinical Trial Screening Across Asia-Pacific

By PREMIA, Holdings (HK) Ltd. Source: GlobeNewswire
PREMIA and Lind Form Lind Asia to Expand AI-Powered Clinical Trial Screening Across Asia-Pacific

PREMIA and Lind have formed Lind Asia, a joint venture to expand AI-powered clinical trial screening technology across the Asia-Pacific region. The partnership aims to leverage artificial intelligence to improve patient recruitment and trial efficiency in clinical research. The venture represents a significant expansion of both companies' capabilities in the growing Asian healthcare market.

Read Full Article at GlobeNewswire

Related Articles